证券日报网讯 7月29日晚间，陆家嘴发布公告称，公司第十届监事会第五次会议审议通过了《2025年半 年度报告及摘要》。 （文章来源：证券日报） ...

证券日报网讯 7月29日晚间，陆家嘴发布公告称，公司第十届董事会第五次会议审议通过了《2025年半 年度报告及摘要》等多项议案。 （文章来源：证券日报） ...

陆家嘴2025半年报 ...

今日聚焦 1、药明康德：拟将回购股份价格上限调整为不超114.15元/股 药明康德公告称，拟将2025年第一次以集中竞价交易方式回购A股股份的回购股份价格上限由不超过 90.72元/股（含）调整为不超过114.15元/股，本次回购方案的其他内容不变。小财注：药明康德今日收 盘价98.69元/股。 2、时空科技：终止筹划控制权变更事项 股票复牌 时空科技公告称，公司收到控股股东、实际控制人宫殿海通知，由于双方未能就某些核心条款达成一 致，决定终止筹划控制权变更事项。相关交易方未就本次交易具体方案签署实质性协议，各方对终止本 次交易无需承担违规责任。目前公司各项业务经营情况正常，终止筹划本次控制权变更事项不会对公司 经营业绩和财务状况产生重大不利影响。公司股票将于7月30日开市起复牌。 3、东安动力：间接控股股东变更为中国长安汽车 东安动力公告称，经国务院批准，兵器装备集团实施存续分立，分立为兵器装备集团（存续企业）和中 国长安汽车（新设企业）。分立前兵器装备集团持有的辰致集团100%股权分立至中国长安汽车，兵器 装备集团不再持有东安动力股份。本次收购后，中国长安汽车通过辰致集团间接持有东安动力2.38亿股 股份 ...

Major Events - Xizang Tianlu announced that its convertible bond "Tianlu Convertible Bond" experienced significant abnormal trading fluctuations, with a cumulative closing price increase of over 100% from July 21 to July 29, 2025, closing at 481.80 yuan per bond, representing a premium of 381.80% over the face value and a conversion premium rate of 16.60% [1] - Huqin Technology plans to acquire 6% of Jinghe Integrated's shares for 2.393 billion yuan, purchasing 120 million shares at a price of 19.88 yuan per share, marking its first stake in the company [2] - Liyuan Technology's actual controller, Shen Wanzhong, received a criminal judgment for violating information disclosure regulations, sentenced to one year in prison with a one and a half year probation, and fined 3.3 million yuan, but this will not significantly impact the company's operations [3] - Huashi Technology announced the lifting of detention measures against its actual controller and general manager, Ye Jianbiao, allowing him to resume his duties [4] - Dongfang Materials' chairman, Xu Guangbin, resigned due to personal reasons but will continue as a board member [5] - WuXi AppTec adjusted its share repurchase price limit from 90.72 yuan to 114.15 yuan per share [6] Performance Overview - Greenland Holdings reported a contract sales amount of 21.752 billion yuan in Q2 2025, a year-on-year increase of 16.93%, with a total sales area of 2.217 million square meters, up 31.03% from the previous year [7] - Lujiazui's H1 2025 net profit was 815 million yuan, a decrease of 7.87%, despite a revenue increase of 33.91% to 6.598 billion yuan [8] - Hongfa Co. achieved a net profit of 964 million yuan in H1 2025, a year-on-year increase of 14.19%, with revenue of 8.347 billion yuan, up 15.43% [9] - Nanya New Materials expects a net profit of 80 million to 95 million yuan in H1 2025, representing a year-on-year increase of 44.69% to 71.82% due to increased sales and improved product structure [9] - Sains expects a net profit decline of 57.53% to 60.13% in H1 2025, with revenue between 410 million and 440 million yuan, a year-on-year increase of 15.17% to 23.59% [9] - Baotai anticipates a net loss of 110 million to 140 million yuan in H1 2025, a reduction in losses compared to the previous year, attributed to increased sales of a specific product and reduced R&D expenses [9] Major Contracts - China CNR announced the signing of several major contracts totaling approximately 32.92 billion yuan, accounting for 13.4% of its projected revenue for 2024 [10] - Wantong Zhikong signed an exclusive authorization agreement with Shanghai Shenming Aosi Semiconductor Technology for the sales and cooperation in the field of embodied intelligence [11] - Anhui Construction won a bid for a highway concession project in Chongqing, with an estimated total investment of 3.614 billion yuan [11] Shareholding Changes - Jiahe Meikang's shareholder, Guoshou Chengda, plans to reduce its stake by up to 3% through various trading methods [12] - Lanfeng Biochemical's shareholder, Hainan Wenqin, intends to reduce its stake by up to 2.61% [12]

Group 1 - Anhui Construction won a joint bid for the Chongqing Rongchang to Sichuan Zigong expressway project, with a total estimated investment of 3.614 billion yuan and a construction period of 3 years [1] - Hongfa Co. reported a net profit of 964 million yuan for the first half of 2025, a year-on-year increase of 14.19%, with revenue of 8.347 billion yuan, up 15.43% [1][2] - Lujiazui's net profit for the first half of 2025 was 815 million yuan, a decrease of 7.87%, despite a revenue increase of 33.91% to 6.598 billion yuan [3] - Enhua Pharmaceutical achieved a net profit of 700 million yuan, up 11.38%, with revenue of 3.010 billion yuan, an increase of 8.93% [4][5] - China CNR signed several major contracts totaling approximately 32.92 billion yuan, covering various sectors including urban rail vehicles and wind power equipment [6] - WanTong Intelligent signed an exclusive sales and cooperation agreement in the embodied intelligence field, gaining global sales rights for specific chip-based products [7][8] Group 2 - Liansheng Technology's subsidiary received a government subsidy of 13.5 million yuan, accounting for 12.24% of the company's latest audited net profit [9] - Guobang Pharmaceutical reported a net profit of 456 million yuan, a year-on-year increase of 12.60%, with revenue of 3.026 billion yuan, up 4.63% [10] - Baotai expects a net loss of 110 to 140 million yuan for the first half of 2025, a reduction in loss compared to the previous year [11] - Sains expects a net profit decrease of 57.53% to 60.13%, with projected revenue growth of 15.17% to 23.59% [12] - Nanya New Materials anticipates a net profit of 80 to 95 million yuan for the first half of 2025, an increase compared to the previous year [13] - Tian Pharmaceutical's subsidiary passed the consistency evaluation for a peritoneal dialysis solution [14] Group 3 - Shede Liquor announced the resignation of director Ni Qiang due to work reasons [15] - Greentown Water plans to transfer assets and liabilities of its ASEAN subsidiary to improve resource allocation [16] - Beibu Gulf Port's subsidiary signed an associated transaction contract worth 11.199 million yuan [17] - Beibu Gulf Port announced multiple resignations of directors and executives [18] - Jidian Co. reported the resignation of its deputy general manager due to work changes [19] - Wanhua Chemical's industrial park in Fujian resumed production after maintenance [20] Group 4 - Shanghai Pharmaceuticals received approval for a clinical trial of a new indication for its B019 injection [21] - Jianbang Co. reported a net profit of 69.66 million yuan, a decrease of 27.72%, with revenue of 307 million yuan, down 15.37% [23] - Jianbang Co. plans to use up to 400 million yuan of idle funds for cash management [25] - Wanfu Bio's subsidiary obtained multiple medical device registrations [28] - Hunan Tianyan announced a change in its controlling shareholder to China Chang'an Automobile Group [29][30] - Xizhuang Co. plans to establish a joint venture for sustainable aviation fuel [32]

陆家嘴（SH 600663，收盘价：9.45元）7月29日晚间发布公告称，公司第十届第五次董事会会议于2025 年7月29日在公司本部以现场方式召开。会议审议了《关于提名公司第十届董事会董事候选人的议案》 等文件。 2024年1至12月份，陆家嘴的营业收入构成为：房产销售占比48.24%，房地产租赁占比22.19%，物业管 理占比14.88%，金融业收入占比9.14%，酒店业占比3.64%。 （文章来源：每日经济新闻） ...

（文章来源：每日经济新闻） 陆家嘴（SH 600663，收盘价：9.45元）7月29日晚间发布半年度业绩报告称，2025年上半年营业收入约 65.98亿元，同比增加33.91%；归属于上市公司股东的净利润约8.15亿元，同比减少7.87%；基本每股收 益0.1619元，同比减少11.96%。 ...

陆家嘴(600663.SH)发布2025年半年度报告，报告期内，公司实现营业收入65.98亿元，同比增长 33.91%。实现归属于上市公司股东的净利润8.15亿元，同比下降7.87%。实现归属于上市公司股东的扣 除非经常性损益的净利润8.28亿元，同比下降6.67%。基本每股收益0.1619元。 ...

三、2025 年 1-6 月，公司实现办公项目销售现金流入 6.39 亿元，权益销售 现金流入 3.51 亿元。 四、2025 年 1-6 月，公司竣工项目为川沙 C06-01/02 地块、川沙 C06-03 地 块、张江中区 74-01 地块，竣工面积 41.02 万平方米，权益竣工面积 36.9 万平 方米。 B股 900932 陆家B股 上海陆家嘴金融贸易区开发股份有限公司 2025 年第二季度房地产业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 股票代码：A股 600663 证券简称：陆家嘴 编号：临2025-029 根据上海证券交易所《上市公司行业信息披露指引第一号——房地产》要求， 特此公告公司 2025 年第二季度主要经营数据如下： 一、至二季度末，公司持有的主要在营物业总建筑面积 396 万平方米，其中： 甲级写字楼的总建筑面积 245 万平方米，高品质研发楼的总建筑面积 33 万平方 米，商业物业的总建筑面积 78 万平方米，酒店物业的总建筑面积 27 万平方米， 租赁住宅物业的总建筑面 ...